Merck, Moderna Detail Potential Skin Cancer Vaccine Progress

2022-12-14 18:17:34

by Merck, Moderna Detail Potential Skin Cancer Vaccine Progress

Moderna’s stock soared Tuesday after the COVID-19 vaccine maker detailed progress in developing a preventive shot for a deadly form of skin cancer. The company said a possible melanoma vaccine it is studying with pharmaceutical giant Merck fared well in... Read More